Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.

about

Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.

Item

http://www.wikidata.org/entity/Q38963111

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic value of endocrine ...... reast cancer: a meta-analysis.

@en

type

Item

label

Prognostic value of endocrine ...... reast cancer: a meta-analysis.

@en

prefLabel

Prognostic value of endocrine ...... reast cancer: a meta-analysis.

@en

P1476

Prognostic value of endocrine ...... reast cancer: a meta-analysis.

@en

P2093

Fei Xu

http://www.w3.org/2001/XMLSchema#string

Ge Qin

http://www.w3.org/2001/XMLSchema#string

Qianyi Lu

http://www.w3.org/2001/XMLSchema#string

Qiufan Zheng

http://www.w3.org/2001/XMLSchema#string

Ruoxi Hong

http://www.w3.org/2001/XMLSchema#string

Shusen Wang

http://www.w3.org/2001/XMLSchema#string

Tao Qin

http://www.w3.org/2001/XMLSchema#string

Wen Xia

http://www.w3.org/2001/XMLSchema#string

Yanxia Shi

http://www.w3.org/2001/XMLSchema#string

Zhongyu Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Aspirin intake and survival after breast cancer

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Measuring inconsistency in meta-analyses

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Skin blood flow in adult human thermoregulation: how it works, when it does not, and why.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?

P2888

s10549-016-3995-5

P304

197-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S10549-016-3995-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021507787

http://www.w3.org/2001/XMLSchema#string

P698

27663434

http://www.w3.org/2001/XMLSchema#string